Merck is scouting sites for a new research hub in the Bay Area, plans new hires
Merck’s R&D reorganization in the U.S. includes finding a new research hub in the Bay Area, with plans to add 100 more investigators as they beef up their ranks for new oncology and cardio programs. And the pharma giant eventually plans to consolidate all its R&D efforts in the region into one central campus.
A spokesperson outlined the plans to me after The Daily Journal in The Peninsula quoted officials in South San Francisco saying that Merck was looking to establish a central hub in the thriving biotech hot spot. The city also hosts research groups from Johnson and Johnson, Pfizer and Roche, along with a host of smaller companies.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
